|
1
|
Bray F, Jemal A, Grey N, Ferlay J and
Forman D: Global cancer transitions according to the human
development index (2008–2030): A population-based study. Lancet
Oncol. 13:790–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in china,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abnet CC, Arnold M and Wei WQ:
Epidemiology of esophageal squamous cell carcinoma.
Gastroenterology. 154:360–373. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang W, Wei C, Li P, Wang L, Li W, Chen K,
Zhang J, Zhang W and Jiang G: Integrative analysis of mRNA and
lncRNA profiles identified pathogenetic lncRNAs in esophageal
squamous cell carcinoma. Gene. 661:169–175. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mariette C, Balon JM, Piessen G, Fabre S,
Van Seuningen I and Triboulet JP: Pattern of recurrence following
complete resection of esophageal carcinoma and factors predictive
of recurrent disease. Cancer. 97:1616–1623. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nigro JM, Cho KR, Fearon ER, Kern SE,
Ruppert JM, Oliner JD, Kinzler KW and Vogelstein B: Scrambled
exons. Cell. 64:607–613. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu J, Shu Y, Xu T, Zhu W, Qiu T, Li J,
Zhang M, Xu J, Guo R, Lu K, et al: Microarray expression profiling
and bioinformatics analysis of circular RNA expression in lung
squamous cell carcinoma. Am J Transl Res. 10:771–783.
2018.PubMed/NCBI
|
|
10
|
Luo YH, Zhu XZ, Huang KW, Zhang Q, Fan YX,
Yan PW and Wen J: Emerging roles of circular RNA hsa_circ_0000064
in the proliferation and metastasis of lung cancer. Biomed
Pharmacother. 96:892–898. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin Q, Ling YB, Chen JW, Zhou CR, Chen J,
Li X and Huang MS: Circular RNA circCDK13 suppresses cell
proliferation, migration and invasion by modulating the JAK/STAT
and PI3K/AKT pathways in liver cancer. Int J Oncol. 53:246–256.
2018.PubMed/NCBI
|
|
12
|
Jiang W, Wen D, Gong L, Wang Y, Liu Z and
Yin F: Circular RNA hsa_circ_0000673 promotes hepatocellular
carcinoma malignance by decreasing mir-767-3p targeting set.
Biochem Biophys Res Commun. 500:211–216. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang C, Yuan W, Yang X, Li P, Wang J, Han
J, Tao J, Li P, Yang H, Lv Q and Zhang W: Circular RNA circ-ITCH
inhibits bladder cancer progression by sponging miR-17/miR-224 and
regulating p21, PTEN expression. Mol Cancer. 17:192018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu C, Yu Y and Ding F: Microarray analysis
of circular RNA expression profiles associated with gemcitabine
resistance in pancreatic cancer cells. Oncol Rep. 40:395–404.
2018.PubMed/NCBI
|
|
15
|
Huang WJ, Wang Y, Liu S, Yang J, Guo SX,
Wang L, Wang H and Fan YF: Silencing circular RNA hsa_circ_0000977
suppresses pancreatic ductal adenocarcinoma progression by
stimulating miR-874-3p and inhibiting PLK1 expression. Cancer Lett.
422:70–80. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sand M, Bechara FG, Gambichler T, Sand D,
Bromba M, Hahn SA, Stockfleth E and Hessam S: Circular RNA
expression in cutaneous squamous cell carcinoma. J Dermatol Sci.
83:210–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li F, Zhang L, Li W, Deng J, Zheng J, An
M, Lu J and Zhou Y: Circular RNA itch has inhibitory effect on ESCC
by suppressing the Wnt/β-catenin pathway. Oncotarget. 6:6001–6013.
2015.PubMed/NCBI
|
|
18
|
Su H, Lin F, Deng X, Shen L, Fang Y, Fei
Z, Zhao L, Zhang X, Pan H, Xie D, et al: Profiling and
bioinformatics analyses reveal differential circular RNA expression
in radioresistant esophageal cancer cells. J Transl Med.
14:2252016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC cancer staging manual. 7th. New York,
NY: Springer; 2010
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Granados-Riveron JT and Aquino-Jarquin G:
Does the linear Sry transcript function as a ceRNA for miR-138? The
sense of antisense. Version 2. F1000Res. 3:902014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xie H, Ren X, Xin S, Lan X, Lu G, Lin Y,
Yang S, Zeng Z, Liao W, Ding YQ and Liang L: Emerging roles of
circrna_001569 targeting miR-145 in the proliferation and invasion
of colorectal cancer. Oncotarget. 7:26680–26691. 2016.PubMed/NCBI
|
|
23
|
Chen J, Li Y, Zheng Q, Bao C, He J, Chen
B, Lyu D, Zheng B, Xu Y, Long Z, et al: Circular RNA profile
identifies circPVT1 as a proliferative factor and prognostic marker
in gastric cancer. Cancer Lett. 388:208–219. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang XO, Wang HB, Zhang Y, Lu X, Chen LL
and Yang L: Complementary sequence-mediated exon circularization.
Cell. 159:134–147. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Conn SJ, Pillman KA, Toubia J, Conn VM,
Salmanidis M, Phillips CA, Roslan S, Schreiber AW, Gregory PA and
Goodall GJ: The RNA binding protein quaking regulates formation of
circRNAs. Cell. 160:1125–1134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhong Z, Lv M and Chen J: Screening
differential circular RNA expression profiles reveals the
regulatory role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in
bladder carcinoma. Sci Rep. 6:309192016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hansen TB, Wiklund ED, Bramsen JB,
Villadsen SB, Statham AL, Clark SJ and Kjems J: miRNA-dependent
gene silencing involving Ago2-mediated cleavage of a circular
antisense RNA. EMBO J. 30:4414–4422. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao Y, Alexandrov PN, Jaber V and Lukiw
WJ: Deficiency in the ubiquitin conjugating enzyme UBE2A in
Alzheimer's disease (AD) is linked to deficits in a natural
circular miRNA-7 sponge (circRNA; ciRS-7). Genes (Basel). 7(pii):
E1162016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xia W, Qiu M, Chen R, Wang S, Leng X, Wang
J, Xu Y, Hu J, Dong G, Xu PL and Yin R: Circular RNA
has_circ_0067934 is upregulated in esophageal squamous cell
carcinoma and promoted proliferation. Sci Rep. 6:355762016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sang M, Meng L, Sang Y, Liu S, Ding P, Ju
Y, Liu F, Gu L, Lian Y, Li J, et al: Circular RNA cirs-7
accelerates ESCC progression through acting as a miR-876-5p sponge
to enhance MAGE-a family expression. Cancer Lett. 426:37–46. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi Y, Chen C, Zhang X, Liu Q, Xu JL,
Zhang HR, Yao XH, Jiang T, He ZC, Ren Y, et al: Primate-specific
miR-663 functions as a tumor suppressor by targeting PIK3CD and
predicts the prognosis of human glioblastoma. Clin Cancer Rse.
20:1803–1813. 2014. View Article : Google Scholar
|
|
32
|
Shi Y, Chen C, Yu SZ, Liu Q, Rao J, Zhang
HR, Xiao HL, Fu TW, Long H, He ZC, et al: Mir-663 suppresses
oncogenic function of CXCR4 in glioblastoma. Clin Cancer Res.
21:4004–4013. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zang W, Wang Y, Wang T, Du Y, Chen X, Li M
and Zhao G: miR-663 attenuates tumor growth and invasiveness by
targeting eEF1A2 in pancreatic cancer. Mol Cancer. 14:372015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ma Q, Zhang Y, Liang H, Zhang F, Liu F,
Chen S, Hu Y, Jiang L, Hao Y, Li M and Liu Y: EMP3, which is
regulated by miR-663a, suppresses gallbladder cancer progression
via interference with the MAPK/ERK pathway. Cancer Lett.
420:97–108. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang W, Li J, Guo X, Zhao Y and Yuan X:
miR-663a inhibits hepatocellular carcinoma cell proliferation and
invasion by targeting HMGA2. Biomed Pharmacother. 81:431–438. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang Y, Zhou X, Xu X, Zhang M, Wang X,
Bai X, Li H, Kan L, Zhou Y, Niu H and He P: Waltonitone induces
apoptosis through mir-663-induced Bcl-2 downregulation in non-small
cell lung cancer. Tumour Biol. 36:871–876. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pan J, Hu H, Zhou Z, Sun L, Peng L, Yu L,
Sun L, Liu J, Yang Z and Ran Y: Tumor-suppressive mir-663 gene
induces mitotic catastrophe growth arrest in human gastric cancer
cells. Oncol Rep. 24:105–112. 2010.PubMed/NCBI
|
|
38
|
Wang Z, Zhang H, Zhang P, Dong W and He L:
MicroRNA-663 suppresses cell invasion and migration by targeting
transforming growth factor beta 1 in papillary thyroid carcinoma.
Tumour Biol. 37:7633–7644. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang Y, Wang LL, Wang HX, Guo ZK, Gao XF,
Cen J, Li YH, Dou LP and Yu L: The epigenetically-regulated miR-663
targets H-Ras in K-562 cells. FEBS J. 280:5109–5117. 2013.
View Article : Google Scholar : PubMed/NCBI
|
